|

Effects of idebenone on
memory impairment induced in ischemic and embolization models of cerebrovascular
disturbance in rats.
Yamazaki N, Kiyota Y, Take Y, Miyamoto M, Nagawa Y, Nagaoka A.
Central Research Division,
Takeda Chemical Industries, Ltd., Osaka, Japan.
Arch Gerontol Geriatr 1989 May;8(3):213-24
ABSTRACT
Two rat models of memory
impairment in passive avoidance learning induced by cerebrovascular
disturbance, were established to estimate the effects of a cerebral metabolic
enhancer, idebenone. Transient and global cerebral ischemia in rats, produced
by 4-vessel occlusion for 200 s immediately after the acquisition trial of
passive avoidance learning, shortened the latencies in the retention test
trial performed 24 h later. This retrograde amnesia was reversed significantly
by idebenone
administered orally or intraperitoneally at the doses of 10 and
30 mg/kg before the retention test trial. Idebenone at a dose of 10 mg/kg,
given intraperitoneally before or immediately after the ischemia, also
markedly inhibited the appearance of amnesia. In the second model, permanent
and cerebral hemisphere embolization produced by injecting 2,000 microspheres
into the internal carotid artery, significantly impaired passive avoidance
learning performed 7 days later. The repeated administration of idebenone
(30
mg/kg, i.p.). once a day after the embolization, significantly improved the
impairment of passive avoidance learning in the embolized rats. Furthermore,
physostigmine and arginine-vasopressin as reference compounds improved the
impairment of passive avoidance learning in these models. These findings
suggest that idebenone
ameliorates memory impairment induced by cerebral
vascular disturbance in rats.
Idebenone
- the ultimate anti-aging drug. (article)
Alzheimer's disease
Idebenone in
the treatment of Alzheimer's disease
Idebenone
efficacy of idebenone in the treatment of Alzheimer's
disease
Idebenone
Nerve Growth Factor synthesis stimulators in Alzheimer's
disease
Idebenone
in the treatment of dementia of the Alzheimer type
Idebenone
cognitive enhancement therapy for Alzheimer's
disease
Friedreich's ataxia.
Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.
Idebenone
causes improvement in mitochondrial
cardiomyopathy
Idebenone
cerebellar improvement in Friedreich's ataxia after 3 months
Idebenone effect
of idebenone on cardiomyopathy in Friedreich's ataxia
Idebenone
Friedreich's ataxia and frataxin
Idebenone Frataxin: Its
role in iron metabolism and Friedreich's Ataxia
Idebenone mitochondrial dysfunction in Friedreich's ataxia
Idebenone helps
heart function
in Friedreich's ataxia
MELAS
Idebenone
improves cerebral mitochondrial oxidative metabolism in MELAS
Idebenone
in young patients with mitochondrial encephalomyopathy (MELAS)
Idebenone
therapy in Mitochondrial encephalomyopathy (MELAS)
Idebenone
and Mitochondrial encephalomyopathy (MELAS)
Idebenone
successful therapy with idebenone in Mitochondrial
encephalomyopathy (MELAS)
.
Cardiomyopathy
Idebenone
improvement in mitochondrial cardiomyopathy following
treatment with idebenone
Idebenone
effect of idebenone on
cardiomyopathy in Friedreich's ataxia
.
Leber hereditary optic neuropathy (LHON)
Idebenone
does it shorten the time to visual recovery in Leber hereditary optic
neuropathy?
Idebenone
improvement in a patient with Leber's hereditary optic neuropathy (LHON)
Misc.
Idebenone
use in age-related cognitive disorders
Idebenone
protects hippocampal neurons against beta amyloid neurotoxicity
Idebenone
functions as a potent protective
hepatocyte antioxidant
Idebenone
neuroprotective effects of
idebenone can be attributed to its antioxidant ability
Idebenone
inhibition of brain mitochondrial
swelling
Idebenone
suppression of cold ischemia/reperfusion
injury of liver endothelium
Idebenone
ability to eliminate a nitroxide
radical in the rat
Idebenone
interaction with respiratory complexes of heart
mitochondria
Idebenone
effect on serotonin release and seroton receptors in rats
Idebenone
protects hepatic microsomes against damage in organ preservation solutions
Idebenone
protects against toxicity
induced by low density lipoprotein
Idebenone
protects against disorders due to cerebral hypoxia or
ischemia
Idebenone
protects against toxicity induced by low density
lipoprotein
Idebenone
attenuates neuronal degeneration induced by excitotoxins
Idebenone
augments long-term potentiation in
hippocampal slices in the guinea pig
Idebenoneeffects
on lipid peroxidation
in erythrocytes of stroke-prone, hypertensive rats
Idebenone
brain distribution and its effect on local cerebral
glucose utilization in rats
Idebenone
effects
on acetylcholine levels
in the brains of rats with cerebral ischemia
Idebenone
protective effect of idebenone against hypoxia in mice
Idebenone
improves learning and memory impairment induced in rats
Idebenone
effects
of idebenone on
neurological deficits in stroke-prone rats
Idebenone
effects
on memory induced impairment in rats
Idebenone
effects of idebenone on cerebral blood flow in rats with cerebral ischemia
Idebenone
inhibition
of brain mitochondrial swelling by idebenone
Idebenone
inhibition of platelet aggregation by
idebenone
Idebenone
effects of idebenone on monoamine metabolites of patients
with dementia
Idebenone
effects of idebenone on
metabolism of monoamines and cyclic AMP formation
Idebenone effects
on impairment of radial maze learning in cerebral embolized rats
Idebenone
effect of idebenone on lipid peroxidation in rat
brain homogenate
Idebenone
effects on muricidal behavior in rats with raphe
lesions
Idebenone
inhibitory effect of idebenone on vascular lesions in
hypertensive rats
Vinpocetine | Galantamine | CDP Choline |
Picamilon
Pyritinol | Modafinil | Deprenyl | Piracetam
Home | Order
|